Pituitary, Thyroid & Adrenal Disorders
News
FDA grants approval to weekly growth hormone for adults
Weekly formulation of somapacitan could improve patient compliance.
Latest News
Humira topped drug-revenue list for 2019
Three cytokine inhibitors were among the four best-selling drugs last year.
From the Journals
Evidence mounts for COVID-19 effects on thyroid gland
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid...
From the Journals
Urine screen as part of triple test improves ID of adrenal cancer
A triple-test strategy including a urine steroid test along with imaging and tumor sizing could help reduce unnecessary further imaging and/or...
From the Journals
Levothyroxine: No LV benefit in subclinical hypothyroidism with MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not...
From the Journals
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
News
FDA approves first oral somatostatin analog for acromegaly
The oral drug octreotide offers an alternative to long-term injections for the rare chronic disease.
Conference Coverage
Increased hypothyroidism risk seen in young men with HS
This finding was surprising, according to a researcher.
From the Journals
Thyroid cancer overdiagnosis reaches beyond affluent regions
Trends of overscreening seen in affluent economies appear to be spreading to middle-income countries as scanning becomes available. “In short, it...
From the Journals
Aldosterone-driven hypertension found with unexpected frequency
From the Journals
COVID-19 may cause subacute thyroiditis